We try to predict the share price target for Divis Lab on the basis of their technical analysis chart, their past year's quarterly and annual reports. Divis Lab is India’s second most popular and valuable pharmaceutical company. The present CEO of Divis Lab is Mr. Satchandra Kiran Divi.

Divi’s Laboratories Limited is an Indian multinational company that deals in the pharmaceutical sector. They mainly involve in the production of APIS which have highly dependent on the worldwide market. They have more than 350 Scientists who work there for producing life-saving at a viable price.

We tell you how the shares price of Divis Lab were performed in past years and by using the number of different tools we will try to form technical analysis for future years to Come which you are also, here to see it below.

As we all can see in a chart, Divis Lab follows a cycle range pattern and they also take good support on the Fibonacci retracement. In laymen language, we can see that even their stock price has fallen for a while but its short-term trend is in the positive direction and in an uptrend. Divis lab long-term trend is also in a positive direction and they are also in an uptrend.

We are trying to predict a possible target which the shares of Divis Lab can cross in upcoming years. Our prediction is based upon different tools and terms which include Fibonacci retracement, support, and resistance. So, here we go with your possible targets for the upcoming years which are attached below.

In the year 2023, we again going to predict two possible the target for the share price of Divis Lab which they can attain easily because of their research developed a product that is going to be a life-saving product for mankind so, we predict the first possible target is Rs.7274 and the second possible target is around Rs.8507.

As the charts show they will give good returns in future years to come so, here we predict the first target for the year 2024 is about Rs.9502 and the second possible target which they can attain after showing some the downtrend is about Rs.10568.

As we read the chart for the year 2025, they will move in an uptrend which helps the share price of Divis Lab to increase their price. So, we predict the first target which they can get in the year 2025 is about Rs.11824, and second, the possible target which they can cross in the same year is about Rs.13364.

Also Read: HCL TECH Share Price Target 2022, 2023, 2024, 2025, And 2030

Till the end of this decade, Divis Lab will be the highest revenue-generating company in the pharmaceutical sector in South Asian Countries which include china too. So we predict the first possible target which they can attain in the year 2030 is around Rs.18,034 and the second possible target which they can cross till the end of this decade is around Rs.27,933.

Also Read: M&M Share Price Target 2022, 2023, 2024, 2025, And 2030

As the data are given at ticker.finology.in we are telling you about company last year performance that how they perform in every quarter of last year if you any mismatch of data in from the official site of  Divis Lab we're not responsible for it.

As the data in a chart is available, in the first quarter of the fiscal year 2020 company made net sales of around Rs.1,376.24cr.  and they make out of it around Rs.391.80cr. in the second quarter of the same financial year 2020, they make net sales of Rs.1,709.96 and make a profit of around Rs.492.25cr. same in the third quarter of the financial year 2020 they make sales of Rs.1,713.78cr. and profit of around Rs.513.30cr. which is pretty much higher than other quarters which is the reason for their deals with other pharmaceutical companies for their research-based product.

Also Read: NTPC Share Price Target 2022, 2023, 2024, 2025, And 2030

In the last quarter of 2020, they make net sales of around Rs.1,656.48 and make a profit out of it around Rs.461.24cr. and in the first quarter of the financial year, 2021 company made net sales of about Rs.1,718.39cr. and make a profit from it of around Rs.487.93cr.

As the data are given at ticker.finology.in we are telling you about company last year performance that how they perform in every quarter of last year if you any mismatch of data in from the official site of Divis Lab we're not responsible for it.

In the year 2020, they make sales of Rs.5,310.57, and a profit of around Rs.1,372.71 which is higher than the last 3 years which is the result of their investment in a research-based project. in the year 2021, they make sales of around Rs.6,798.61cr. and make a profit of about Rs.1,954.72 as we can see there from last two years they make good revenue that why I said earlier that till the end of this decade Divis lab will emerge as the highest revenue generating company in India.

In this artical, We have done a detailed analysis of the Divis Lab. We were tried to include every aspect in our artical that is really essential to know before investing in any specific company shares.

Before ending this artical, I am going to tell you some strengths which help Divis Lab to emerge as the highest revenue-generating company at the end of this decade.

1. Strong financial condition.
2. Socially active.
3. Brand value.
4. Advanced knowledge management.
5. More than 300 scientists working on research-based projects.

Also Read: Bajaj Auto Share Price Target 2022, 2023, 2024, 2025, And 2030

If you are having any doubts or questions regarding this artical, you can ask me in a comment section and share this artical with your friends and family members which help them to invest in the right companies and also us to reach millions of people.